AstraZeneca Aktie
119,80
EUR
-0,75
EUR
-0,62
%
102,78
GBP
-0,02
GBP
-0,02
%
Werbung
AstraZeneca Aktie Analyse
| 16.10.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 09.10.17 | AstraZeneca Neutral | UBS AG | |
| 18.09.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 13.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 11.09.17 | AstraZeneca Neutral | UBS AG | |
| 11.09.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 11.09.17 | AstraZeneca Neutral | BNP PARIBAS | |
| 11.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 11.09.17 | AstraZeneca Neutral | Credit Suisse Group | |
| 08.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 01.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 31.08.17 | AstraZeneca Neutral | UBS AG | |
| 24.08.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 09.08.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 01.08.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 01.08.17 | AstraZeneca Neutral | UBS AG | |
| 31.07.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 28.07.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 28.07.17 | AstraZeneca neutral | Credit Suisse Group | |
| 27.07.17 | AstraZeneca Hold | S&P Capital IQ | |
| 27.07.17 | AstraZeneca Neutral | UBS AG | |
| 21.07.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 13.07.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 12.07.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 27.06.17 | AstraZeneca Neutral | UBS AG | |
| 16.06.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 07.06.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 24.05.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 12.05.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 28.04.17 | AstraZeneca market-perform | Bernstein Research | |
| 27.04.17 | AstraZeneca Neutral | UBS AG | |
| 21.04.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 18.04.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 10.04.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 05.04.17 | AstraZeneca Neutral | UBS AG | |
| 15.03.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 20.02.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 07.02.17 | AstraZeneca Hold | HSBC | |
| 07.02.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 03.02.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 26.01.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 04.01.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 12.12.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 28.11.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 02.11.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 26.10.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 19.10.16 | AstraZeneca market-perform | Bernstein Research | |
| 10.10.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 05.10.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 04.10.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
Werbung
Werbung